Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells

Annat Raiter; Rinat Yerushalmi; Britta Hardy

doi:10.18632/oncotarget.2576

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells

Annat Raiter _, Rinat Yerushalmi and Britta Hardy

PDF | HTML | How to cite

Oncotarget. 2014; 5:11452-11463. https://doi.org/10.18632/oncotarget.2576

Metrics: PDF 2042 views | HTML 2815 views | ?

Abstract

Annat Raiter1,*, Rinat Yerushalmi2,*, Britta Hardy1

1Felsenstein Medical Research Center, Tel Aviv University School of Medicine, Rabin Medical Center, Petach Tikva, 49100, Israel

2Oncology Institute, Rabin Medical Center, Petach Tikva, 49100, Israel

*These authors contributed equally to this work

Correspondence to:

Britta Hardy, e-mail: [email protected]

Keywords: triple negative breast cancer cells, drug induced cell surface GRP78, apoptosis

Received: July 16, 2014 Accepted: October 05, 2014 Published: October 24, 2014

ABSTRACT

Breast cancer tumor with triple-negative receptors (estrogen, progesterone and Her 2, receptors) is the most aggressive and deadly subtype, with high rates of disease recurrence and poor survival.

Here, we show that induction in cell surface GRP78 by doxorubicin and tunicamycin was associated with CHOP/GADD153 upregulation and increase in apoptosis in triple negative breast cancer tumor cells.

GRP78 is a major regulator of the stress induced unfolded protein response pathway and CHOP/GADD153 is a pro-apoptotic transcription factor associated exclusively with stress induced apoptosis.

The blocking of cell surface GRP78 by anti-GRP78 antibody prevented apoptosis, suggesting that induction of cell surface GRP78 by doxorubicin and tunicamycin is required for apoptosis.

A better understanding of stress induction of apoptotic signaling in triple negative breast cancer cells may help to define new therapeutic strategies.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 2576

Publication Alerts

Research Papers:

Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells

Abstract